Search research articles
Contact Us
Filters
Showing results (91-100 of 171) with videos related to
Page
of 18
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 1, 1992
Preoperative chemotherapy for osteosarcoma with intravenous adriamycin and intra-arterial cis-platinum
R S Benjamin, S P Chawla, C H Carrasco, et al.
The Journal of the Association of Physicians of India
|
March 29, 2001
An open clinical trial of benazepril--a new ACE inhibitor in mild-moderate hypertension
N D Karnik, Y K Oza, S P Sane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 16, 2025
Development of a First-in-Class Click Chemistry-Based Cancer Therapeutic, from Preclinical Evaluation to a First-in-Human Dose Escalation Clinical Trial
Sangeetha Srinivasan, Nathan A Yee, Maša Alečković, et al.
Annals of Surgical Oncology
|
March 13, 2002
Systemic irinotecan and regional floxuridine after hepatic cytoreduction in 185 patients with unresectable colorectal cancer metastases
David A Litvak, Thomas F Wood, George J Tsioulias, et al.
Seminars in Diagnostic Pathology
|
August 1, 1987
Osteosarcoma chemotherapy effect: a prognostic factor
A K Raymond, S P Chawla, C H Carrasco, et al.
Cancer Chemotherapy and Pharmacology
|
February 13, 2013
Phase I study to assess the pharmacokinetics and the effect on cardiac repolarization of amrubicin and amrubicinol in patients with advanced solid tumors
Nianhang Chen, Sant P Chawla, Elena Gabriela Chiorean, et al.
British Journal of Cancer
|
September 12, 2013
Trabectedin is a feasible treatment for soft tissue sarcoma patients regardless of patient age: a retrospective pooled analysis of five phase II trials
A L Cesne, I Judson, R Maki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 1992
Abrogating chemotherapy-induced myelosuppression by recombinant granulocyte-macrophage colony-stimulating factor in patients with sarcoma: protection at the progenitor cell level
S Vadhan-Raj, H E Broxmeyer, W N Hittelman, et al.
Anticancer Research
|
October 2, 2019
Induction of Metastasis by Low-dose Gemcitabine in a Pancreatic Cancer Orthotopic Mouse Model: An Opposite Effect of Chemotherapy
Norihiko Sugisawa, Kentaro Miyake, Takashi Higuchi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 14, 2012
First-line treatment of metastatic or locally advanced unresectable soft tissue sarcomas with conatumumab in combination with doxorubicin or doxorubicin alone: a phase I/II open-label and double-blind study
George D Demetri, Axel Le Cesne, Sant P Chawla, et al.
Page
of 18
Search research articles
Search
Showing results (91-100 of 171) with videos related to
Sort By:
Page
of 18
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 1, 1992
Preoperative chemotherapy for osteosarcoma with intravenous adriamycin and intra-arterial cis-platinum
R S Benjamin, S P Chawla, C H Carrasco, et al.
The Journal of the Association of Physicians of India
|
March 29, 2001
An open clinical trial of benazepril--a new ACE inhibitor in mild-moderate hypertension
N D Karnik, Y K Oza, S P Sane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 16, 2025
Development of a First-in-Class Click Chemistry-Based Cancer Therapeutic, from Preclinical Evaluation to a First-in-Human Dose Escalation Clinical Trial
Sangeetha Srinivasan, Nathan A Yee, Maša Alečković, et al.
Annals of Surgical Oncology
|
March 13, 2002
Systemic irinotecan and regional floxuridine after hepatic cytoreduction in 185 patients with unresectable colorectal cancer metastases
David A Litvak, Thomas F Wood, George J Tsioulias, et al.
Seminars in Diagnostic Pathology
|
August 1, 1987
Osteosarcoma chemotherapy effect: a prognostic factor
A K Raymond, S P Chawla, C H Carrasco, et al.
Cancer Chemotherapy and Pharmacology
|
February 13, 2013
Phase I study to assess the pharmacokinetics and the effect on cardiac repolarization of amrubicin and amrubicinol in patients with advanced solid tumors
Nianhang Chen, Sant P Chawla, Elena Gabriela Chiorean, et al.
British Journal of Cancer
|
September 12, 2013
Trabectedin is a feasible treatment for soft tissue sarcoma patients regardless of patient age: a retrospective pooled analysis of five phase II trials
A L Cesne, I Judson, R Maki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 11, 1992
Abrogating chemotherapy-induced myelosuppression by recombinant granulocyte-macrophage colony-stimulating factor in patients with sarcoma: protection at the progenitor cell level
S Vadhan-Raj, H E Broxmeyer, W N Hittelman, et al.
Anticancer Research
|
October 2, 2019
Induction of Metastasis by Low-dose Gemcitabine in a Pancreatic Cancer Orthotopic Mouse Model: An Opposite Effect of Chemotherapy
Norihiko Sugisawa, Kentaro Miyake, Takashi Higuchi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 14, 2012
First-line treatment of metastatic or locally advanced unresectable soft tissue sarcomas with conatumumab in combination with doxorubicin or doxorubicin alone: a phase I/II open-label and double-blind study
George D Demetri, Axel Le Cesne, Sant P Chawla, et al.
Page
of 18